Kashiv BioSciences is a biopharmaceutical company that develops and manufactures biosimilars and complex peptide-based medicines.
Kashiv BioSciences has raised $72.3M in total funding. The most recent round was Debt Financing. The last funding was announced in December 2025.
Kashiv BioSciences's investors include GoldenTree Asset Management, Union Bank of India, Tarsadia Investments.
Kashiv BioSciences is headquartered in Piscataway, United States.
Kashiv BioSciences is a biopharmaceutical company that develops and manufactures biosimilars and complex peptide-based medicines.
Kashiv BioSciences is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kashiv BioSciences — Funding & Investors." VCBacked, December 22, 2025, https://www.vcbacked.co/company/kashiv-biosciences. Accessed August 15, 2026.
VCBacked. (2025). Kashiv BioSciences — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/kashiv-biosciences
{{cite web |title=Kashiv BioSciences — Funding & Investors |url=https://www.vcbacked.co/company/kashiv-biosciences |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated